1.Preterm birth research in Southeast Asia and its association with socioeconomic determinants and burden of disease: A bibliometric analysis.
Koleen C. Pasamba ; Jean Anne B. Toral
Acta Medica Philippina 2024;58(11):72-80
Objective:
The aim of this study was to assess research productivity on preterm birth (PTB) in Southeast Asian (SEA) countries and its correlation with socioeconomic characteristics and burden of disease.
Methods:
A systematic review of preterm birth publications by SEA authors indexed in Scopus, PubMed, ClinicalTrials. gov, and Cochrane was done. Case reports, cohorts, control trials, reviews and cost analysis studies done by SEA researches involving pathophysiology, diagnosis, management, and complications of preterm birth was included in the study while published letters to editors were excluded. The correlation of bibliometric indices, namely Scopus citations, and PlumX metrics indices (citations, usage, captures, mentions, and social media), with socioeconomic status and burden of preterm birth in SEA countries were analyzed by computing for the correlation coefficient (r) and p-value at an alpha of 0.05.
Results:
Thailand had the highest number of publications and the highest count across all bibliometric indices among all countries in SEA. The percent gross domestic product (GDP) per capita allotted for research and development (R & D) had direct correlation with publications and captures while crude birth rates had indirect correlation with publications, citations, and captures. Neonatal mortality had indirect correlation with publications and captures.
Conclusion
Support for research and development is essential to increase research productivity in SEA, which in turn may help in finding solutions to decrease the rate of preterm birth in the region.
Bibliometric Analysis
;
Bibliometrics
;
Preterm Birth
;
Premature Birth
;
Gross Domestic Product
;
Asia, Southeastern
2.Lessons learned during the COVID-19 pandemic from the third environmental and occupational health forum
Rose Abigail E. Duarte ; Vivien Fe F. Fadrilan-Camacho ; Harvey C. Domingo ; Paul Michael R. Hernandez ; Maria Fe Theresa C. Lomboy ; Gayline F. Manalang Jr. ; Victorio B. Molina ; Romeo R. Quizon ; Adrian Paul M. Agravante ; May B. Bas ; Jhon Rey C. Bayatan ; Hilda Antonia A. Nique ; Chester C. Ramos ; Dexter C. Tiro ; Crystal Amiel M. Estrada
Philippine Journal of Health Research and Development 2024;28(4):1-1
COVID-19, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, China in late 2019. Rapidly spreading worldwide, it was declared a pandemic by the World Health Organization (WHO) in early 2020 [1]. Various mitigation strategies, such as physical distancing, travel restrictions, and other public health protocols, were enforced globally to curb virus transmission [2,3]. However, these measures also disrupted daily life, work environments, and public health systems, posing significant challenges in balancing virus prevention and continuation of economic activity [4]. This paper aimed to highlight key lessons from the Third Environmental and Occupational Health (EOH) Forum on public health emergency response as demonstrated by selected Asian countries. Proceedings from the forum were reviewed and analyzed, arriving at the following lessons and themes: proactive and strategic public health interventions, leadership and governance, community participation, policy adjustments, technological integration and innovation, and balancing health and economic activities. The forum, themed “Environmental and Occupational Health Initiatives During the COVID-19 Pandemic,” was held virtually in November 2020 [5]. Understanding environmental and occupational health interventions as well as the themes of strategies by Asian countries, provides valuable insights into early pandemic management and contributes to a repository of knowledge that can be adapted and applied globally, enhancing the overall effectiveness of pandemic responses.
Occupational Health
;
Environmental Health
;
Publich Health
;
COVID-19
;
Pandemics
;
Asia
3.Weight bias and stigma in healthcare professionals: a narrative review with a Singapore lens.
Anthony James GOFF ; Yingshan LEE ; Kwang Wei THAM
Singapore medical journal 2023;64(3):155-162
Addressing weight stigma is essential to obesity management as it causes inequalities in healthcare and impacts the outcomes of health. This narrative review summarises systematic review findings about the presence of weight bias in healthcare professionals, and interventions to reduce weight bias or stigma in these professionals. Two databases (PubMed and Cumulative Index to Nursing and Allied Health Literature [CINAHL]) were searched. Seven eligible reviews were identified from 872 search results. Four reviews identified the presence of weight bias, and three investigated trials to reduce weight bias or stigma in healthcare professionals. The findings may help further research and the treatment, health and well-being of individuals with overweight or obesity in Singapore. Weight bias was prevalent among qualified and student healthcare professionals globally, and there is a lack of clear guidance for effective interventions to reduce it, particularly in Asia. Future research is essential to identify the issues and inform initiatives to reduce weight bias and stigma among healthcare professionals in Singapore.
Humans
;
Weight Prejudice
;
Singapore
;
Asia
;
Databases, Factual
;
Health Facilities
4.2021 Asian Pacific Society of Cardiology Consensus Recommendations on the use of P2Y12 receptor antagonists in the Asia-Pacific Region: Special populations.
W E I C H I E H T A N TAN ; P C H E W CHEW ; L A M T S U I TSUI ; T A N TAN ; D U P L Y A K O V DUPLYAKOV ; H A M M O U D E H HAMMOUDEH ; Bo ZHANG ; Yi LI ; Kai XU ; J O N G ONG ; Doni FIRMAN ; G A M R A GAMRA ; A L M A H M E E D ALMAHMEED ; D A L A L DALAL ; T A N TAN ; S T E G STEG ; N N G U Y E N NGUYEN ; A K O AKO ; A L S U W A I D I SUWAIDI ; C H A N CHAN ; S O B H Y SOBHY ; S H E H A B SHEHAB ; B U D D H A R I BUDDHARI ; Zu Lv WANG ; Y E A N Y I P F O N G FONG ; K A R A D A G KARADAG ; K I M KIM ; B A B E R BABER ; T A N G C H I N CHIN ; Ya Ling HAN
Chinese Journal of Cardiology 2023;51(1):19-31
5.Prevalence of colorectal cancer in 2020: a comparative analysis between China and the world.
Chao YAN ; Fei SHAN ; Zi Yu LI
Chinese Journal of Oncology 2023;45(3):221-229
Objective: To demonstrate the disease burden and epidemiological characteristics of colorectal cancer in different regions by analyzing the incidence and mortality data in China and worldwide in 2020. Methods: Estimation of the incidence and mortality data of colorectal cancer were obtained from the GLOBOCAN 2020 database. The incidence, death, age standardized incidence rate (ASIR) and age standardized mortality rate (ASMR) of colorectal cancer in China and 20 regions in the world were compared. The correlation between the Human Development Index (HDI) and ASIR/ASMR was analyzed. Results: In 2020, the number of new cases of colorectal cancer in the world reached 1 931 600, and the number of deaths reached 935 200. The incidence and mortality in all regions of the world continued to rise in the age group above 50 years old. The morbidity and mortality in male were higher than those in female. East Asia ranked the highest number of incidence cases and deaths in the world, which were 740 000 and 360 100 respectively. There were significant differences in incidence and mortality among regions in the world. The highest ASIR and ASMR were observed in Northern Europe (33.61/100 000) and Eastern Europe (14.53/100 000), whereas the lowest ASIR and ASMR were both observed in South-Central Asia (5.46/100 000 and 3.16/100 000). HDI had significant exponential relationship with ASIR (r(2)=0.59, P<0.001) and ASMR (r(2)=0.38, P<0.001). There were 555 500 new cases and 286 200 death cases of colorectal cancer in China, accounting for about 30% of the world and more than 75% of East Asia. The ASIR of China was 24.07/100 000, ranking at the medium level, while the ASMR was 12.07/100 000, ranking at the high level of world. Conclusion: The incidence and mortality of colorectal cancer are highly correlated with HDI. China is one of the countries with the heaviest disease burden of colorectal cancer in the world.
Humans
;
Male
;
Female
;
Middle Aged
;
Prevalence
;
China/epidemiology*
;
Asia/epidemiology*
;
Incidence
;
Colorectal Neoplasms/epidemiology*
6.Treatment and outcomes of high-risk neuroblastoma in Southeast Asia: a single-institution experience and review of the literature.
Anselm Chi-Wai LEE ; Chan Hon CHUI ; Robert KWOK ; Kim Shang LEE ; Chee Meng FONG ; Wilfred Hing-Sang WONG
Singapore medical journal 2023;64(5):319-325
INTRODUCTION:
In Europe and North America, the majority of children with high-risk neuroblastoma survive the disease. Elsewhere, the treatment outcomes are poor.
METHODS:
A retrospective review of children treated for high-risk neuroblastoma in a single institution in Singapore from 2007 to 2019 was carried out. Treatment consisted of intensive chemotherapy, surgery aimed at gross total resection of residual disease after chemotherapy, consolidation with high-dose therapy followed by autologous stem cell rescue, and radiotherapy to the primary and metastatic sites followed by maintenance treatment with either cis-retinoic acid or anti-disialoganglioside monoclonal antibody therapy. Survival data were examined on certain clinical and laboratory factors.
RESULTS:
There were 57 children (32 male) treated for high-risk neuroblastoma. Their mean age was 3.9 (range 0.7-14.9) years. The median follow-up time was 5.5 (range 1.8-13.0) years for the surviving patients. There were 31 survivors, with 27 patients surviving in first remission, and the five-year overall survival and event-free survival rates were 52.5% and 47.4%, respectively. On log-rank testing, only the group of 17 patients who were exclusively treated at our centre had a survival advantage. Their five-year overall survival rate compared to patients whose initial chemotherapy was done elsewhere was 81.6% versus 41.1% (P = 0.011), and that of event-free survival was 69.7% versus 36.1% (P = 0.032). Published treatment results were obtained from four countries in Southeast Asia with five-year overall survival rates from 13.5% to 28.2%.
CONCLUSION
Intensified medical and surgical treatment for high-risk neuroblastoma proved to be effective, with superior survival rates compared to previous data from Southeast Asia.
Child
;
Humans
;
Male
;
Infant
;
Child, Preschool
;
Adolescent
;
Disease-Free Survival
;
Neuroblastoma/pathology*
;
Hematopoietic Stem Cell Transplantation/methods*
;
Treatment Outcome
;
Antineoplastic Combined Chemotherapy Protocols/therapeutic use*
;
Asia, Southeastern/epidemiology*
;
Combined Modality Therapy
7.Analysis on the trends of incidence and age change for global female breast cancer.
Xin LIANG ; Jian YANG ; Ting GAO ; Rong Shou ZHENG
Chinese Journal of Oncology 2023;45(4):313-321
Objective: To analyze the trends of incidence and age change for global female breast cancer in different regions of the world according to the database from Cancer Incidence in Five Continents Time Trends (CI5plus) published by the International Association of Cancer Registries (IACR). Methods: The recorded annual female breast cancer (ICD-10: C50) incidence data and corresponding population at-risk data (1998-2012) were extracted from CI5plus published by IACR. The annual change percentage and average annual change percentage (AAPC) were calculated to examine the trends of incidence. The age-standardized mean age at diagnosis and proportion of incidence cases by age were calculated to analyze the relationship between incidence and age. Results: For crude incidence, except in Northern America, all other regions showed an upward trend, with Asia showing the most obvious upward trend (AAPC: 4.1%, 95% CI: 3.9%, 4.3%). For age-standardized incidence, in Asia, Latin America and Europe, the rising trends had slowed down, in Oceania and Africa, the trends began to be stable, and in Northern America, the trend showed a downward trend (APPC: -0.6%; 95% CI: -1.0%, -0.1%). The mean age at diagnosis were increased from 1998 to 2012 in Asia, Latin America, Oceania and Europe, with an annual increase of 0.12 years, 0.09 years, 0.04 years and 0.03 years, respectively. But after age-standardized, only Europe still kept increasing year by year, with an annual increase of 0.02 years, while Northern America showed a decreasing trend, with an annual decrease of about 0.03 years. Conclusions: From 1998 to 2012, the trends of incidence and age change for global female breast cancer vary in different regions of the world, and the global population aging is widespread, which affects the trend of the actual age change. Prevention and control strategies should be targeted at different age groups in different regions.
Humans
;
Female
;
Breast Neoplasms/epidemiology*
;
Incidence
;
Asia/epidemiology*
;
Europe/epidemiology*
;
Risk Factors
8.COVID-19 vaccine hesitancy in ASEAN: Insights from a multi-wave survey database from July 2020 to March 2021
Kenneth Y. Hartigan-Go ; Ronald U. Mendoza ; Madeline Mae A. Ong ; Jurel K. Yap
Acta Medica Philippina 2023;57(1):10-16
Objectives:
Early studies on COVID-19 vaccine hesitancy showed varied intensity across countries, which was linked to various factors such as socio-economic conditions, information sources, and issues of trust in government, scientific experts, and the health sector. This study aims to evaluate the determinants of vaccine hesitancy to offer insights into the strategies that may be successful in designing communications campaigns for enhanced vaccination uptake.
Methods:
Through logistic regression, this study examines correlates of survey data from five Southeast Asian countries, namely Indonesia (ID), Malaysia (MY), Philippines (PH), Thailand (TH), Vietnam (VN) collected by the Massachusetts Institute of Technology Initiative on Digital Economy and Facebook between July 2020 and March 2021.
Results:
Some significant determinants at the 5% or 1% level of significance of COVID-19 vaccine hesitancy in the countries of interest include gender [ID: 1.17 (1.01, 1.15), MY: 1.35 (1.2,1.53), PH: 1.92 (1.68,2.19), VN: 1.28 (1.04,1.58)], age [MY:1.11 (1.06,1.17), PH: 0.92 (0.88, 0.97), TH: 1.17 (1.11, 1.23)], knowing someone who tested positive for COVID-19 [ID: 0.75 (0.65,0.88), MY: 0.82 (0.71,0.95), PH: 0.76 (0.67, 0.87), TH: 0.76 (0.59, 0.99), VN: 0.72 (0.54,0.97)], and perceived effectiveness of mask wearing [ID: 0.83 (0.74, 0.94), MY: 0.86 (0.79, 0.95), TH: 0.88 (0.8,0.98)]. Vaccine hesitancy is particularly strong among women in 3 countries—peaking at 52% in Indonesia, 42% in Malaysia, and 56% in the Philippines.
Conclusion
Results from the survey highlight the significance of a targeted vaccine education and research campaign. This study calls for streamlining of communications campaigns towards messages that promote vaccine uptake in the region, while better targeting those groups most vulnerable guided by the empirical findings herein.
Asia
9.Psychiatric morbidities after stroke in Asia: A systematic review
Meliza Angelica J. De Leon ; Alejandro C. Baroque II
Journal of Medicine University of Santo Tomas 2023;7(2):1222-1228
Background:
Stroke is currently the second leading cause of death worldwide and is one of the leading causes of long-term disability . Mood disorders are prevalent after a stroke and may hinder physical, functional, and cognitive recovery; hence, it is undeniably necessary to recognize them early. Stroke mortality is generally higher in Asia as most of the countries therein are in economic transition . Socioeconomic status is a major contributor to stroke burden as greater odds of disability are found in patients with lower educational status and income.
Objectives:
The primary objective of this study is to identify the psychiatric morbidities commonly seen after a stroke in Asia.
Search Methods:
The following databases were utilized for extensive literature search: PubMed (January 2002 to June 2022), Cochrane Library (January 2002 to June 2022), and EBSCO (January 2002 to June 2022). The search made use of keyword combinations, Boolean operators "AND" and "OR," truncations, and field tags last October 2022.
Selection Criteria:
Articles on the prevalence and cross-sectional studies were included if they involved stroke survivors who developed post-stroke psychiatric morbidities in Asia. Additional inclusion criteria consisted of studies that have to be written in the English language and having free full texts available.
Data Collection and Analysis:
This systematic review made use of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards and guidelines. The JBI Critical Appraisal Checklist for Studies Reporting Prevalence Data was used in the assessment for the quality of articles to be included in this systematic review.
Results and Conclusion
Affective disorders and generalized anxiety disorder were the common psychiatric morbidities identified post-stroke. The Hospital Anxiety and Depression Scale (HADS) may be used to diagnose post-stroke depression and anxiety. Males in their middle to late adulthood with higher National Institutes of Health Stroke Scale (NIHSS) scores and poor stroke outcomes (higher scores in the Modified Rankin Scale) were associated with a higher likelihood of developing the aforementioned psychiatric morbidities.
Depression
;
Anxiety
;
Mania
;
Psychotic Disorders
;
Asia
10.Research on applying genetic and environmental risk score in risk-adapted colorectal cancer screening.
Chen Yu LUO ; Yu Han ZHANG ; Ming LU ; Bin LU ; Jie CAI ; Na LI ; Yue Yang ZHOU ; Jia Hui LUO ; Ding Ding ZHANG ; Xin Zhuang YANG ; Hong Da CHEN ; Min DAI
Chinese Journal of Epidemiology 2023;44(6):999-1005
Objective: To evaluate the effectiveness of a risk-adapted colorectal cancer screening strategy constructed utilizing genetic and environmental risk score (ERS). Methods: A polygenic risk score (PRS) was constructed based on 20 previously published single nucleotide polymorphisms for colorectal cancer in East Asian populations, using 2 160 samples with MassARRAY test results from a multicenter randomized controlled trial of colorectal cancer screening in China. The ERS was calculated using the Asia-Pacific Colorectal Screening Score system. Logistic regression was used to analyze the association between PRS alone and PRS combined with ERS and colorectal neoplasms risk, respectively. We also designed a risk-adapted screening strategy based on PRS and ERS (high-risk participants undergo a single colonoscopy, low-risk participants undergo an annual fecal immunochemical test, and those with positive results undergo further diagnostic colonoscopy) and compared its effectiveness with the all-acceptance colonoscopy strategy. Results: The high PRS group had a 26% increased risk of colorectal neoplasms compared with the low PRS group (OR=1.26, 95%CI: 1.03-1.54, P=0.026). Participants with the highest PRS and ERS were 3.03 times more likely to develop advanced colorectal neoplasms than those with the lowest score (95%CI: 1.87-4.90, P<0.001). As the risk-adapted screening simulation reached the third round, the detection rate of the PRS combined with ERS strategy was not statistically different from the all-acceptance colonoscopy strategy (8.79% vs. 10.46%, P=0.075) and had a higher positive predictive value (14.11% vs. 10.46%, P<0.001) and lower number of colonoscopies per advanced neoplasms detected (7.1 vs. 9.6, P<0.001). Conclusion: The risk-adapted screening strategy combining PRS and ERS helps achieve population risk stratification and better effectiveness than the traditional colonoscopy-based screening strategy.
Humans
;
Early Detection of Cancer
;
Risk Factors
;
Colorectal Neoplasms/genetics*
;
Asia
;
China/epidemiology*


Result Analysis
Print
Save
E-mail